Schizophrenia and type 2 diabetes are linked, but GLP-1s could help manage the risks
trthaber.com - 2026-10-15
Treatment with glucagon-like peptide-1 receptor agonists (GLP-1s) was associated with lower risks of psychiatric hospitalization and psychiatric emergency department visits in people with both schi...